| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Dez―31 |
ZnO-carbon nanomaterials-based hybrid platforms for electrochemical sensing of favipiravir as an antiviral medication for COVID-19 |
Mobina Neshati, Bahare Sabeti, Fereshteh Chekin |
| 2 |
[GO] |
2024―Dez―16 |
Simulation-based insights into Remdesivir coating on Ag nanoparticles for optimized COVID-19 drug delivery |
Seyedeh Seddigheh Mousavian, Farhad Shirini, Hossein Taherpour Nahzomi |
| 3 |
[GO] |
2024―Jan―31 |
An in-silico investigation of volatile compounds in Tulsi and Ginger as a potent inhalant for SARS-CoV-2 treatment |
J. Jayashankar, G. N. Ningaraju, S. Nanjundaswamy, Jothi Ramalingam Rajabathar, Muthusamy Karnan, C. S. Karthik, P. Mallu |
| 4 |
[GO] |
2021―Nov―23 |
Naphthalene-based bis-N-salicylidene aniline dyes: Crystal structures, Hirshfeld surface analysis, computational study and molecular docking with the SARS-CoV-2 proteins |
Tatyana M. Burkhanova, Maria G. Babashkina, Tugba Taskin-Tok, Artem V. Sharov, Damir A. Safin |
| 5 |
[GO] |
2021―Okt―26 |
High predictive QSAR models for predicting the SARS coronavirus main protease inhibition activity of ketone-based covalent inhibitors |
Bakhtyar Sepehri, Mohammad Kohnehpoushi, Raouf Ghavami |
| 6 |
[GO] |
2021―Aug―17 |
Molecular docking studies on COVID-19 and antibacterial evaluation of newly synthesized 4-(methoxymethyl)-1,2,3-triazolean analogues derived from (E)-1-phenyl-3-(2-(piperidin-1-yl)quinolin-3-yl) prop-2-en-1-one |
M. Nagamani, T. Vishnu, P. Jalapathi, M. Srinivas |
| 7 |
[GO] |
2021―Aug―17 |
Heterocyclic compounds derived from cyclohexane-1,4-dione: synthesis of tetrahydro-4H-chromene and tetrahydrobenzo[d]thiazole derivatives as target SARS-CoV-2 main protease (Mpro) and potential anti-Covid-19 |
Rafat Milad Mohareb, Nadia Youssef Megally Abdo |
| 8 |
[GO] |
2021―Aug―09 |
Synthesis, spectroscopic characterization, and thermal studies of novel Schiff base complexes: theoretical simulation studies on coronavirus (COVID-19) using molecular docking |
Yasmin M. Ahmed, M. M. Omar, Gehad G. Mohamed |
| 9 |
[GO] |
2021―Jul―26 |
Synthesis and characterization of ferrocene-based thiosemicarbazones along with their computational studies for potential as inhibitors for SARS-CoV-2 |
Rifat Jawaria, Muhammad Usman Khan, Mazhar Hussain, Shabbir Muhammad, Muhammad Sagir, Amjad Hussain, Abdullah G. Al-Sehemi |
| 10 |
[GO] |
2021―Jun―04 |
Vital role of water in longevity of SARS-CoV-2 and enhancing its binding with human cells |
Gholamabbas Parsafar, Vinay Reddy |
| 11 |
[GO] |
2021―Mrz―26 |
Repositioning therapeutics for COVID-19: virtual screening of the potent synthetic and natural compounds as SARS-CoV-2 3CLpro inhibitors |
Ahmad Sattari, Ali Ramazani, Hamideh Aghahosseini |
| 12 |
[GO] |
2021―Feb―26 |
A review on the syntheses of Dronabinol and Epidiolex as classical cannabinoids with various biological activities including those against SARS-COV2 |
Neda Tadayon, Ali Ramazani |
| 13 |
[GO] |
2020―Sep―07 |
The ACE2 as a “rescue protein” or “suspect enzyme” in COVID-19: possible application of the “engineered inactive hrsACE2” as a safer therapeutic agent in the treatment of SARS-CoV-2 infection |
Reza Khodarahmi, Babak Sayad, Mahsa Sobhani |
| 14 |
[GO] |
2020―Apr―24 |
Achilles' heel of the killer virus: the highly important molecular targets for hitting SARS-CoV-2 that causes COVID-19 |
Reza Yousefi, Ali Akbar Moosavi-Movahedi |
